The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Why Does This Male Patient with Rheumatic Heart Disease Have Congestive Heart Failure?
March 11th 2015The patient is a 48-year-old male with "heart trouble" since the age of 6 years, after having rheumatic fever. He was treated with digitalis and diuretics until he was 31 years of age when he was admitted for heart failure and underwent closed commissurotomy.
NYU to Highlight 'Fascinating' Research at ACC Conference
March 10th 2015The American College of Cardiology conference in San Diego, CA will feature some of the biggest heart health news from around the world during its annual meeting March 14-16. Among the presentations will be several from doctors and researchers at New York University.
ACC Meeting Preview: Changing the Practice of Cardiology
The American College of Cardiology 2015 Annual Scientific Session and Expo is set to begin March 14 in San Diego, CA. MD Magazine's editorial and video team will be there to provide breaking news, physician interviews, and analysis of the 3-day event. Some of the studies presented will likely change the practice of cardiology. Here's a preview.
Better Tools for Predicting Post-Surgery Risk of Atrial Fibrillation
A simple CHADS2 score, along with records about ongoing use of certain medications, may help physicians predict the risk that individual patients will develop atrial fibrillation after thoracic or vascular surgery.
Testosterone Replacement Therapy Not Associated with Increased Risk of Cardiovascular Events in Men
March 9th 2015Study results show that men with stable coronary heart disease or acute coronary syndrome who received testosterone replacement therapy did not experience higher rates of major adverse cardiovascular events than men who did not receive testosterone replacement therapy.
Stronger Hearts Helpline Offers Heart Failure Referrals, Information
The National Forum for Heart Disease & Stroke Prevention is rolling out a free 24/7 information hotline called Stronger Hearts where callers can get referrals to care and information about heart failure. The program, which has funding from Novartis, began in February, 2015 as a pilot in San Bernardino County, CA. Its backers hope to expand the concept to other markets where demographics indicate a high prevalence of heart failure patients.
Effect of Testosterone and Estradiol on Cardiovascular Disease Risk in Men
March 8th 2015Study results presented at ENDO 2015 suggest that some risk factors associated with cardiovascular disease are regulated by testosterone and estradiol, others (such as changes in LDL cholesterol and blood pressure) are not.
Weighing the Risks of Quitting Smoking and Obesity
One of the major concerns of people considering quitting smoking is whether they will gain weight. A new study has shown that may not need to be a concern and that the overall benefits to their health can outweigh the risks.
Liraglutide Associated with Improved Glycemic Control in Overweight Patients with Prediabetes
March 6th 2015In overweight and obese individuals without diabetes, liraglutide 3.0 mg as an adjunct to diet and exercise was associated with greater reductions in fasting and postprandial glucose compared with diet and exercise alone.
More Good News on Mediterranean Diet
Being Greek does not necessarily mean eating healthy. A new study showed that adults in Greece who ate a traditional Mediterranean style diet-one that stresses eating fresh fruits and vegetables, whole grains, beans, nuts, fish, olive oil and moderate consumption of red wine-were 47% less likely to develop heart disease than peers who were eating Western-style. A related study, however, showed that physicians often do not know enough about the diet to counsel patients.
Research Finds Heart Failure Timetable
It's no secret that behavior can alter a person's likelihood of developing heart failure. In a new set of metrics, Faraz Ahmad, MD and colleagues at Northwestern University offer physicians a tool to show how many healthy heart-failure free years patients can gain by avoiding risky behaviors.
Kids, Cholesterol and Blood Pressure: Tracking Change
March 5th 2015The National Health and Nutrition Examination Survey (NHANES) has tracked changes in dyslipidemia and blood pressure in children since 1988. A new report in JAMA Pediatrics indicated that serum lipid concentrations improved in American children and adolescents since 1988.
Two days after the US Food and Drug Administration announced that testosterone replacement products must now carry warning labels on the risks of heart attack and stroke, 2 researchers presented abstracts of studies indicating that there is no such danger. The studies were publicized by the American College of Cardiology and will be presented in detail at the group's upcoming meeting in San Diego, CA.
Palpatations and Light-Headedness: Another 'Typical' Day
March 4th 2015A 73 year-old man presents to the emergency department from his internist's office where he had complained of palpitations and light-headedness that began 4 hours earlier after his daily exercise regimen. He did not appear distressed, but his heart rate was 160 beats per minute. Blood pressure was 140/90. He had no light-headedness at the time, but continued to report palpitations. An ECG was performed.